Loading data
IRLANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 35.38 m USD | 18.59 m USD | 9.45 m USD | 25.18 m USD | 60.8 m USD |
| Operating profit | -58.07 m USD | -57.29 m USD | -34.62 m USD | -52.02 m USD | -90.32 m USD |
| Profit before tax | -80.77 m USD | -56.74 m USD | -31.58 m USD | -51.94 m USD | -89.95 m USD |
| Income tax expense | 3.21 m USD | 87 k USD | -197 k USD | -284 k USD | 0 USD |
| Net income (reported basis) | -83.98 m USD | -56.83 m USD | -31.39 m USD | -51.66 m USD | -89.95 m USD |
| Basic earnings per share | -1.68 USD/share | -1.31 USD/share | -0.84 USD/share | -1.54 USD/share | -3.03 USD/share |
| Diluted earnings per share | -1.68 USD/share | -1.31 USD/share | -0.84 USD/share | -1.54 USD/share | -3.03 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.